-
公开(公告)号:DE69909897D1
公开(公告)日:2003-09-04
申请号:DE69909897
申请日:1999-05-14
Applicant: IDEXX LAB INC
Inventor: GROAT RANDALL G , MERMER BRION , O'CONNOR THOMAS P
IPC: C07K7/08 , C07K14/155 , G01N33/569
Abstract: We disclose methods for determining whether a feline is infected with feline immunodeficiency virus ("FIV"). The methods involve the use of an antibody-binding composition that includes two enhanced polypeptides, one containing an immunogenic fragment of the FIV gag precursor p55 and the other containing an immunogenic fragment of the FIV env precursor gp130. Also disclosed are devices for practising these methods.
-
公开(公告)号:AU6401800A
公开(公告)日:2001-03-05
申请号:AU6401800
申请日:2000-08-09
Applicant: IDEXX LAB INC
Inventor: GUO HONGLIANG , LAWTON ROBERT , MERMER BRION , AIYAPPA ASHOK P
-
公开(公告)号:DE69922873D1
公开(公告)日:2005-02-03
申请号:DE69922873
申请日:1999-04-09
Applicant: IDEXX LAB INC
Inventor: LAWTON ROBERT , MERMER BRION , FRANCOEUR GREG
-
公开(公告)号:AU754309B2
公开(公告)日:2002-11-14
申请号:AU2806799
申请日:1999-05-11
Applicant: IDEXX LAB INC
Inventor: GROAT RANDALL G , O'CONNOR THOMAS P , MERMER BRION
IPC: C07K7/08 , C07K14/155 , G01N33/569 , G01N33/571
Abstract: We disclose methods for determining whether a feline is infected with feline immunodeficiency virus ("FIV"). The methods involve the use of an antibody-binding composition that includes two enhanced polypeptides, one containing an immunogenic fragment of the FIV gag precursor p55 and the other containing an immunogenic fragment of the FIV env precursor gp130. Also disclosed are devices for practising these methods.
-
公开(公告)号:AU2806799A
公开(公告)日:1999-11-25
申请号:AU2806799
申请日:1999-05-11
Applicant: IDEXX LAB INC
Inventor: GROAT RANDALL G , MERMER BRION , O'CONNOR THOMAS P
IPC: C07K7/08 , C07K14/155 , G01N33/569 , G01N33/571
Abstract: We disclose methods for determining whether a feline is infected with feline immunodeficiency virus ("FIV"). The methods involve the use of an antibody-binding composition that includes two enhanced polypeptides, one containing an immunogenic fragment of the FIV gag precursor p55 and the other containing an immunogenic fragment of the FIV env precursor gp130. Also disclosed are devices for practising these methods.
-
公开(公告)号:CA2271449A1
公开(公告)日:1999-11-15
申请号:CA2271449
申请日:1999-05-14
Applicant: IDEXX LAB INC
Inventor: MERMER BRION , O'CONNOR THOMAS P , GROAT RANDALL G
IPC: C07K7/08 , C07K14/155 , G01N33/569 , C12Q1/70 , G01N33/577
Abstract: Methods for determining whether a feline is infected with feline immunodeficiency virus ("FIV"). The methods involve the use of an antibody-binding composition that includes two enhanced polypeptides, one containing an immunogenic fragment of the FIV gag precursor p55 and the other containing an immunogenic fragment of the FIV env precursor gp130. Also featured a.re devices for practicing these methods.
-
17.
公开(公告)号:AU2125697A
公开(公告)日:1997-09-02
申请号:AU2125697
申请日:1997-02-14
Applicant: IDEXX LAB INC
Inventor: MERMER BRION , HARRIS RACHEL A , SIEFRING ANN E
-
公开(公告)号:CA2329148C
公开(公告)日:2012-05-29
申请号:CA2329148
申请日:2000-03-30
Applicant: IDEXX LAB INC
Inventor: LAWTON ROBERT , MERMER BRION , FRANCOEUR GREG
Abstract: Disclosed are binding proteins that specifically bind to an isolated and purified peptide comprising a leucine positioned two peptide bonds away from a tyrosine-arginine pair. Other binding proteins of the invention include those that specifically bind to an isolated and purified peptide with the sequence cysteine-blank-blank-proline-histidine-blank-blank-blank-cysteine (SEQ ID NO:6) or cysteine-blank-proline-histidine-blank-proline-blank-blank-cysteine (SEQ ID NO:9).
-
公开(公告)号:DE60127237D1
公开(公告)日:2007-04-26
申请号:DE60127237
申请日:2001-01-30
Applicant: IDEXX LAB INC
Inventor: LAWTON ROBERT L , AIYAPPA ASHOK P , LIU WENDY W , MERMER BRION , GUO HONGLIANG , KRAH EUGENE R
Abstract: The present invention provides methods and compositions for decreasing IgE levels in dogs. The methods and compositions are useful for treating allergic symptoms in dogs. The invention may comprise chimeric canine anti-IgE monoclonal antibody compositions and methods for using the compositions in the treatment of allergy. In preferred embodiments, the compositions of the present invention may act by binding soluble IgE in plasma, or by inhibiting IgE from binding to receptors on mast cells, B cells, and basophils.
-
公开(公告)号:DE69922873T2
公开(公告)日:2005-12-29
申请号:DE69922873
申请日:1999-04-09
Applicant: IDEXX LAB INC
Inventor: LAWTON ROBERT , MERMER BRION , FRANCOEUR GREG
-
-
-
-
-
-
-
-
-